Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Axos Financial
AX
$5.68B
| $53.5M | 0.12% |
2,915,200
+52,800
| +2% | +$1.04M |
|
177
Berkshire Hathaway Class B
BRK.B
$1.11T
| $53.5M | 0.12% |
422,400
-198,600
| -32% | -$25.1M |
|
178
Tyler Technologies
TYL
$13.2B
| $53.3M | 0.12% |
584,800
-143,690
| -20% | -$11.7M |
|
179
Tapestry
TPR
$32.4B
| $52.9M | 0.12% |
+1,546,900
| New | +$66.4M |
|
180
Usana Health Sciences
USNA
$254M
| $52.8M | 0.12% |
1,351,800
+42,834
| +3% | +$1.59M |
|
181
Loews
L
$23.1B
| $52.6M | 0.12% |
1,196,000
+1,165,708
| +3,848% | +$50.9M |
|
|
TARO
182
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $52.1M | 0.12% |
371,200
+102,800
| +38% | +$11.4M |
|
|
GA
183
DELISTED
GIANT INTERACTIVE GROUP INC ADR (CAYMAN ISLANDS)
GA
| $52M | 0.12% |
4,391,164
+1,413,764
| +47% | +$16.6M |
|
184
Occidental Petroleum
OXY
$59B
| $51.9M | 0.12% |
527,574
+195,066
| +59% | +$18.3M |
|
185
A.O. Smith
AOS
$8.65B
| $51.5M | 0.12% |
2,078,400
-148,864
| -7% | -$3.57M |
|
|
CSGS
186
DELISTED
CSG Systems International
CSGS
| $51.5M | 0.12% |
1,973,022
+105,185
| +6% | +$2.74M |
|
|
CSC
187
DELISTED
Computer Sciences
CSC
| $51.3M | 0.12% |
1,926,639
+1,887,660
| +4,843% | +$48.9M |
|
188
Zebra Technologies
ZBRA
$18.1B
| $51.2M | 0.12% |
622,100
+100,664
| +19% | +$7.34M |
|
|
MZTI
189
The Marzetti Company
MZTI
$3.15B
| $51.1M | 0.12% |
537,500
+58,800
| +12% | +$5.44M |
|
190
DTE Energy
DTE
$28.6B
| $50.7M | 0.12% |
765,160
-361,313
| -32% | -$23.4M |
|
191
Nokia
NOK
$52.7B
| $50.1M | 0.12% |
6,625,900
+6,185,600
| +1,405% | +$47M |
|
192
Dollar General
DG
$26.5B
| $50.1M | 0.12% |
+872,900
| New | +$49.9M |
|
193
Synopsys
SNPS
$78.7B
| $50.1M | 0.12% |
1,289,334
-202,066
| -14% | -$7.71M |
|
194
KBR
KBR
$4.74B
| $49.9M | 0.12% |
2,094,000
+1,718,498
| +458% | +$43.1M |
|
195
Constellation Brands
STZ
$22.9B
| $49.9M | 0.12% |
566,000
+261,307
| +86% | +$21.6M |
|
196
Liberty Media Series A
FWONA
$23.4B
| $49.3M | 0.11% |
2,030,122
-366,457
| -15% | -$8.41M |
|
197
lululemon athletica
LULU
$14.3B
| $49.1M | 0.11% |
1,213,400
+455,900
| +60% | +$20.8M |
|
|
SRC
198
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $48.9M | 0.11% |
960,037
+849,117
| +766% | +$42.2M |
|
199
Cheniere Energy
LNG
$54.8B
| $48.8M | 0.11% |
+681,100
| New | +$41.4M |
|
200
First Solar
FSLR
$25.9B
| $48.7M | 0.11% |
685,100
+39,087
| +6% | +$2.59M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.